Here we report a bioactive peptide (PAP) derived from the Pak1 autoinhibitory region increases Pak1 activity, counteracts Ang II-induced pathological hypertrophy in in vitro and in vivo models and associated ventricular arrhythmias in in vivo models. This evidence concerns the gene AGT and Ventricular arrhythmia.